Don't Miss a Beat: Updates in the Management of Heart Disease
Friday, February 9, 2:15-3:15 PM
Accredited for Pharmacists Only
This session will take a deeper dive into the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Content will review the revised stages and classifications of heart failure, summarize key recommendations for guideline-directed medical therapy, and identify patient-centered strategies crucial for optimizing treatment outcomes. Learners will gain a better understanding of the pharmacist's pivotal role in heart failure care as they apply evidence-based knowledge to craft effective care plans and improve patient outcomes.
Accredited for Pharmacists Only
This session will take a deeper dive into the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Content will review the revised stages and classifications of heart failure, summarize key recommendations for guideline-directed medical therapy, and identify patient-centered strategies crucial for optimizing treatment outcomes. Learners will gain a better understanding of the pharmacist's pivotal role in heart failure care as they apply evidence-based knowledge to craft effective care plans and improve patient outcomes.
Learning Objectives - Pharmacists
Upon successful completion of this application-based CPE activity, participants should be able to:
- Review revised stages and classifications of heart failure.
- Summarize recommendations for guideline-directed medical therapy in heart failure.
- Identify patient-centered strategies to optimize the treatment of heart failure.
- Explore the role of pharmacists in caring for patients with heart failure.
- Apply evidence-based knowledge to develop a heart failure care plan that improves patient outcomes.
0.1 CEU/1 hr
UAN: 0107-0000-23-374-L01-P
Natalie R. Gadbois-Mincks, PharmD, MPA, BCACP
Clinical Assistant Professor, Drake University College of Pharmacy and Health Sciences